Poster sessions

Wednesday Thursday Friday

Authors to be presented in front of their posters

    Wednesday, November 7, 13:45-14:30  
     Abstract no.  Author  Title
PO 01         45  A.C.H. de Vries  Molecular aberration in children with MDS 
PO 02     63  A.C.H. de Vries  Mitochondrial DNA mutations in MDS
PO 03     27  A. Goncalves Silva  Arra-CGH in myeloid neoplasms
PO 04     47  D.O. Vidal  Microarray-based DNA methylation analysis in MDS/JMML
PO 05     73  E.D.R.P. Velloso  Cytogenetics from Brazil
PO 06   102  G. Göhring  Clonal evolution of complec karyotypes in MDS with 5q-
PO 07       9  A. Catala  MDS with 5q deletion
PO 08       7  M. Torrebadell  Secondary MDS with t(3;21)
PO 09     21  L. Lizcova  Rare recurrent aberrations involving chromosome 7
PO 10     88  F.G.J. Calkoen  Mesenchymal stem cells from children with MDS/JMML
PO 11     65  S. Bresolin  Case of monozygotic twins with concordant JMML
PO 12     50  H. Muramatsu  Somatic mosaicism for oncogenic RAS mutations in JMML
PO 13     78  C. Diakos  Differenetial methylation in JMML
PO 14     74  F. Timeus  Noon syndrome and MPS evolution
PO 15       8  N. Yasui  Aggressive transformation of JMML caused by RAS
PO 16     40  Y. Honda  Clinical characteristics of 23 children with JMML in blast crisis
PO 17   100  L.M. Ball  IL-1 receptor antagonist treatment of MAS in JMML
PO 18     60  H. Ueno  Two children with MDS presented HLH
PO 19     31  M. Yabe  Allogeneic HSCT for 30 children with JMML
PO 20     62  J.W. Lee  Long-term survival with autologous recovery for JMML
PO 21     43  N. Bhatnagar  Transient leukemia in neonates with DS
PO 22   107  M. Kaymak-Cihan  Case with therapy-related MDS
PO 23     93  S. Cross  Even in a little places…
         
   Thursday, November 8, 13:15 – 14:00  
   
PO 24       5  V. de Haas  Pediatric BM failure: CCOG online central review
PO 25   106  P.G. Guedes Granja  Hematological Profile of pts with persistent cytopenias
PO 26     87  L.F. Lopes  GCB-SMD-PED: Is it relevant to improve..
PO 27     77  M. van den Akker  Impact of underlying cathegory, cytopathology..
PO 28     61  A. Shimada  Chemotherapy is beneficial for RAEB and RAEBt
PO 29   105  P. Riha  Characteristics of late relapses in pts with MDS
PO 30     58  M. Ussowitz  Therapeutical interventions in MDS or JMML
PO 31     17  P. Keslova  Late effects following HSCT for MDS/JMML
PO 32       4  D.G. Valerio  Collaboratrive EWOG-MDS Vidaza study
PO 33     86  A. Seber  Use of azacytidin to prevent relapse
PO 34     18  S. Polychronopoulou  Refractory cytopenia of childhood
PO 35     28  S. Polychronopoulou  Long-term FUP of children with aplastic anemia
PO 36     33  D. Hasegawa  Treatment outcome of 67 cases with refractory cytopenia
PO 37     68  A. M. Aalbers  Clinical signifikance of minor PNH clones
PO 38     25  G. Aydogan  Successful management of PNH by eculizumab
PO 39     66  P.F. I. Krell  Massive parallel sequencing in SAA
PO 40     53  M. Salamonowitz  Side effects during ATG therapy
PO 41     56  Y. Takahashi  Rabbit ATG and cyclosporine in children with SAA
PO 42     76  H. Yagasaki  Outcome of IST in fulminant SAA
PO 43     81  D. Yilmaz Karapinar  Rabbit ATG
PO 44   103  L. Krol  Late effects in pediatric pts after HSCT for SAA
PO 45     48  T. N. Masmas  Hepatitis-associated aplastic anemia
PO 46     35  K. Watanabe  Allogeneic HSCT for secondary MDS after SAA
PO 47     32  K. Pawelec  Negative impact of iron overload in SAA
         
     Thursday, November 8, 15:30 – 16:30
 
PO 48     92  I. Furlan  Ring chromosome 21: from LAD to MDS
PO 49     42  N. Bhatnagar  Clonal myelodysplasia in associaation with PID
PO 50     71  D. Yilmaz Karapinari  MDS with mycobacterium fortuitum infection
PO 51     94  E. Mejstrikova  Selective granule deficiency presenting ….
PO 52     72  A. Janda  Variable presentation of GATA-2 deficiency
PO 53     20  A. Makis  Familial occurence of MDS
PO 54     69  G. Avgerinou  Clinical course….children with MPN
PO 55     39  A. Shimada  De novo childhood MDS/MPN-U disease
PO 56     80  D. Pospisilova  Essential thrombocythaemia in children
PO 57     67  V. Campr  BM trephine biopsy findings in thrombocythaemia
PO 58     49  D. Pospisilova  Effects of an leucine administration in DBA
PO 59     85  A. Akyay  Primary hyperparathyroidism
PO 60     84  A. Akyay  Mylofibrosis associated with vitamin D
PO 61       6  M. van Grotel  Hypereosinophilic syndrome in children
PO 62     51  T. Votava  Successful treatment of HES
PO 63     15  M. Cada  Clonal and malignant myeloid transformation
PO 64     97  F. Rahim  DNA repair gene and risk …
PO 65     91  L. Olcay  Granulocytic and non granulocytic lineages..
PO 66   101  D. Steinemann  Leukemias developed in pts with congenital neutropenias
PO 67       1  Z. Kovalova  Unexpectedly high incidence of Fanconi anemia
PO 68     55  J. Sevilla  Reesults of fludarabine and TCD for FA
PO 69     16  P. Keslova  Hepatopulmonary syndrome after SCT
PO 70     98  M. Sukova  Heterogeneity of severe forms of CDA
PO 71     41  H. F. Heijnen  Autophagy is a major mediator in ribosomopathies
PO 72     70  D. Longoni  Mesenchymal stem cells from SDS

 

 

   
 
Symposium Secretariat: CZECH-IN s.r.o., 5. kvetna 65, 140 21 Prague 4, CZE | tel.: +420 261 174 301 | fax: +420 261 174 307
Home | Sitemap | [email protected]
Copyright © 2011 ewogmds2012.com | Powered and created by E-WORKS - web studio | XHTML 1.0 | CSS 2